Search

  2. ProQR Announces Expert Perspectives Conference Call Series

    Press release

    … ProQR Announces Expert Perspectives Conference Call Series … & CAMBRIDGE, Mass., June 12, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Drs. Girach and Koenekoop will also discuss QR-421a, ProQR’s investigational therapy for patients with Usher …

  4. ProQR Announces Extraordinary General Meeting of Shareholders

    Press release

    … ProQR Announces Extraordinary General Meeting of Shareholders … be made available in the ‘Investor Relations’section of ProQR’s website ( www.proqr.com ) under ‘Financial Information’.  The documents …

  5. ProQR Announces Pricing of Initial Public Offering

    Press release

    LEIDEN, Netherlands, Sept. 18, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics today announced the pricing of its initial public offering of 7,500,000 ordinary shares at an initial public offering price of $13.00 per ordinary share.

  6. ProQR to Present at Two Upcoming Conferences

    Press release

    … ProQR to Present at Two Upcoming Conferences LEIDEN, the Netherlands, April 03, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … at 9:25 am CET, Daniel de Boer, Chief Executive Officer of ProQR, will present at the H.C. Wainwright Global Life …

  9. Lilly and ProQR to Expand RNA Editing Collaboration

    Press release

    … Lilly and ProQR to Expand RNA Editing Collaboration New agreement … assets directed toward high conviction targets utilizing ProQR’s Axiomer technology INDIANAPOLIS; LEIDEN, Netherlands; …

  10. ProQR Announces Proposed Public Offering of Ordinary Shares

    Press release

    … ProQR Announces Proposed Public Offering of Ordinary Shares … LEIDEN, the Netherlands, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … public offering.  All of the shares are being offered by ProQR.  In addition, in the public offering, ProQR expects to …